Umoja Biopharma Presents Data on its Synthetic Cytokine Receptor Platform at the International Society for Cell and Gene Therapy Annual Meeting 2022

3 years ago

RACR-induced cytotoxic innate lymphocytes permit the expansion and differentiation of iPSCs with fewer limitations, leading to a more cost-effective manufacturing…

Marker Therapeutics to Present Four Posters on its T Cell-Based Immunotherapies at the 2022 International Society for Cell & Gene Therapy Annual Meeting

3 years ago

HOUSTON, May 04, 2022 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of…

NATO Center of Excellence for Military Medicine to Study Brain Scientific’s NeuroCap Device

3 years ago

Brain Scientific partner LOK Corporation will illustrate the advantages of expanding EEG access with Brain Scientific’s neurology productsLAKEWOOD RANCH, Fla.,…

Annual General Meeting of Infant Bacterial Therapeutics

3 years ago

At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 4, 2022, among other things, the following…

TOWER ONE ANNOUNCES FILING OF ITS Q4 AND YEAR 2021 ANNUAL REPORT

3 years ago

First year with positive EBITDA(1)Miami, FL, May 04, 2022 (GLOBE NEWSWIRE) -- TOWER ONE WIRELESS CORP. (CSE: TO) (OTCQB: TOWTF)…

Cloud DX Signs Third Paramedical Service Provider with Peterborough County Paramedics

3 years ago

Paramedical Providers bring Remote Patient Monitoring (RPM) to Community CareNews in SummaryPeterborough County is the third Paramedical Provider to sign…

Rezolute, Inc. Announces Closing of Registered Direct Offering

3 years ago

REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing…

<div>Jupiter Wellness’ to Present JW-300 Topical Burn Treatment at SCALE 2022 Aesthetic Medicine, Plastic Surgery & Medical Dermatology Conference</div>

3 years ago

JW-300 Demonstrated Efficacy in the Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo-Controlled Clinical TrialJUPITER, FL / ACCESSWIRE /…

Cyclacel Pharmaceuticals to Release First Quarter 2022 Financial Results

3 years ago

BERKELEY HEIGHTS, N.J., May 04, 2022 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"),…

Pressure BioSciences Announces First Nanoemulsions Manufacturing Agreement Under Recently Released UST Early Access Program

3 years ago

Company Signs Development & Manufacturing Agreement with Safer Medical of Montana for Formulation, Pilot Batches, and Commercial Production of CBD…